Chemed Corp. (NYSE:CHE) updated its FY17 earnings guidance on Thursday. The company provided earnings per share guidance of $8.35-$8.40 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $8.19.
A number of brokerages have recently weighed in on CHE. Oppenheimer Holdings, Inc. increased their target price on Chemed Corp. from $220.00 to $225.00 and gave the stock an outperform rating in a research note on Friday, October 27th. Zacks Investment Research downgraded Chemed Corp. from a buy rating to a hold rating in a research report on Wednesday, September 13th. BidaskClub downgraded Chemed Corp. from a buy rating to a hold rating in a research report on Wednesday, August 2nd. Finally, Royal Bank Of Canada reaffirmed a hold rating and issued a $209.00 target price on shares of Chemed Corp. in a report on Monday, July 31st. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. The company currently has a consensus rating of Hold and a consensus target price of $236.00.
Chemed Corp. (CHE) traded down $0.01 during midday trading on Friday, hitting $231.12. The company had a trading volume of 97,500 shares, compared to its average volume of 93,727. The firm has a market cap of $3,690.00, a P/E ratio of 28.49, a price-to-earnings-growth ratio of 4.89 and a beta of 1.14. The company has a debt-to-equity ratio of 0.15, a quick ratio of 0.48 and a current ratio of 0.50. Chemed Corp. has a 12 month low of $143.87 and a 12 month high of $235.96.
Chemed Corp. (NYSE:CHE) last announced its earnings results on Thursday, October 26th. The company reported $2.15 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.00 by $0.15. Chemed Corp. had a return on equity of 27.69% and a net margin of 4.62%. The business had revenue of $417.40 million during the quarter, compared to analyst estimates of $414.34 million. During the same period last year, the company earned $1.73 EPS. Chemed Corp.’s revenue for the quarter was up 6.3% compared to the same quarter last year. equities research analysts anticipate that Chemed Corp. will post 4.73 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 4th. Stockholders of record on Monday, November 13th will be given a $0.28 dividend. This represents a $1.12 annualized dividend and a dividend yield of 0.48%. The ex-dividend date is Friday, November 10th. Chemed Corp.’s dividend payout ratio (DPR) is presently 24.94%.
In other news, VP Naomi C. Dallob sold 750 shares of the firm’s stock in a transaction dated Tuesday, October 31st. The stock was sold at an average price of $222.09, for a total value of $166,567.50. Following the completion of the sale, the vice president now directly owns 9,097 shares in the company, valued at approximately $2,020,352.73. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Patrick P. Grace sold 500 shares of the firm’s stock in a transaction dated Monday, October 2nd. The shares were sold at an average price of $201.48, for a total value of $100,740.00. Following the completion of the sale, the director now owns 4,515 shares of the company’s stock, valued at $909,682.20. The disclosure for this sale can be found here. Over the last three months, insiders sold 15,650 shares of company stock valued at $3,480,193. Corporate insiders own 4.90% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Chemed Corp. (NYSE:CHE) Releases FY17 Earnings Guidance” was published by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this news story can be accessed at https://stocknewstimes.com/2017/11/11/chemed-corp-che-updates-fy17-earnings-guidance.html.
About Chemed Corp.
Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.
Receive News & Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related companies with MarketBeat.com's FREE daily email newsletter.